Pettyjohn Wood & White’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
3,458
-620
-15% -$230K 0.19% 84
2026
Q1
$1.19M Sell
4,078
-360
-8% -$118K 0.19% 88
2025
Q4
$1.56M Buy
4,438
+119
+3% +$40.2K 0.24% 77
2025
Q3
$1.4M Buy
4,319
+14
+0.3% +$4.35K 0.23% 81
2025
Q2
$1.67M Buy
4,305
+314
+8% +$126K 0.3% 72
2025
Q1
$1.74M Sell
3,991
-122
-3% -$49K 0.33% 67
2024
Q4
$1.52M Sell
4,113
-434
-10% -$182K 0.28% 76
2024
Q3
$2.36M Sell
4,547
-51
-1% -$27.2K 0.44% 59
2024
Q2
$2.49M Sell
4,598
-22
-0.5% -$11.6K 0.48% 52
2024
Q1
$2.4M Buy
4,620
+71
+2% +$35.3K 0.48% 50
2023
Q4
$2.15M Hold
4,549
0.46% 53
2023
Q3
$1.98M Sell
4,549
-15
-0.3% -$6.8K 0.47% 52
2023
Q2
$2.03M Buy
4,564
+68
+2% +$31.4K 0.47% 52
2023
Q1
$2.07M Sell
4,496
-62
-1% -$29.5K 0.51% 50
2022
Q4
$2.34M Sell
4,558
-12
-0.3% -$6.09K 0.58% 49
2022
Q3
$2.08M Sell
4,570
-129
-3% -$61.7K 0.55% 52
2022
Q2
$2.27M Sell
4,699
-92
-2% -$45.5K 0.54% 53
2022
Q1
$2.35M Sell
4,791
-173
-3% -$79.1K 0.5% 55
2021
Q4
$2.3M Sell
4,964
-144
-3% -$60.6K 0.47% 54
2021
Q3
$1.9M Sell
5,108
-155
-3% -$58.9K 0.42% 57
2021
Q2
$2.01M Sell
5,263
-175
-3% -$66.9K 0.45% 57
2021
Q1
$1.95M Buy
5,438
+623
+13% +$200K 0.46% 57
2020
Q4
$1.55M Buy
4,815
+166
+4% +$50.9K 0.39% 62
2020
Q3
$1.25M Sell
4,649
-435
-9% -$117K 0.37% 60
2020
Q2
$1.34M Sell
5,084
-15
-0.3% -$4K 0.43% 57
2020
Q1
$1.16M Buy
5,099
+270
+6% +$73.6K 0.43% 55
2019
Q4
$1.46M Buy
4,829
+350
+8% +$96.3K 0.42% 56
2019
Q3
$1.07M Sell
4,479
-5
-0.1% -$1.37K 0.33% 68
2019
Q2
$1.26M Buy
+4,484
New +$1.22M 0.39% 61

Other funds holding ELV

Pettyjohn Wood & White's ELV Position: Q2 2026 in Review

Pettyjohn Wood & White reduced its Elevance Health (ELV) stake by 15% in Q2 2026, selling an estimated $230K and leaving 3,458 shares worth $1.34M. The position accounts for 0.19% of the portfolio, ranked #84.

Pettyjohn Wood & White first reported a position in ELV in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.49M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Pettyjohn Wood & White held 3,458 shares of Elevance Health worth $1.34M as of Q2 2026.
  • Pettyjohn Wood & White sold 620 Elevance Health shares in Q2 2026, an estimated $230K.
  • Elevance Health made up 0.19% of Pettyjohn Wood & White's portfolio in Q2 2026, its #84 holding.
  • Pettyjohn Wood & White first reported a position in Elevance Health in Q2 2019 and has held it in 29 quarters since.
  • Pettyjohn Wood & White's Elevance Health position peaked at $2.49M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pettyjohn Wood & White's 13F filing for Q2 2026, filed 12 Aug 2026.